Patent Search
Patent search US patent no . 7138408 A ) The tile of this patent is : HIV integrase inhibitors pharmaceutical compositions and methods for their use Inventors : Kuki Asuo (US Li Xinqiang (US Plewe Michael B (US Wang Hai (US Zhang Junhu (US Assignees : Aqouron Pharmaceuticals , Inc Beta-carboline hydroxamic acid compounds represented by formula (I STR00001 is used in this patent . These compounds and compositions containing those compounds are sued to inhibit or modulate the activity of HIV integrase enzyme and to treat diseases and conditions occurring due to HIV

integrase
This patent has 6 claims . These are
1 A compound of formula (lb , EMI28 .0
A pharmaceutical composition , consisting of therapeutically effective amount of at
least one compound according to claim 1 , and a diluent , carrier or vehicle
acceptable pharmaceutically
3 A method of inhibiting or modulating the HIV virus , by contacting the enzyme of virus through one of the compounds in claim 1
4 . A method treating a disease or condition occurring due to HIV virus integrase
enzyme . This comprises of administering therapeutically effective amount of at least
one compound according to claim 1 , to mammals
5 . A method to replicate the treatment given to mammals in claim 4 , for the humans
6 . A method of inhibiting the activity of HIV integrase enzyme by comprising of
contacting said virus with HIV integrase enzyme-inhibiting the amount of compound
according to claim ( US patent 7138408
New Technology
This new technology is titled as : Use of Chemical Compounds to Stimulate the
Endoplasmic Reticulum (ER ) Stress Response in Tumor Cells Causing Tumor Cell Death
In brief , this technology provides a pathway by which specific drugs kill the tumor cells
This pathway is endoplasmic reticulum (ER ) stress response . 2 ,5 dimethyl-celecoxib (DMC
and related compounds trigger the ER stress response and related compounds trigger the ER
stress response and as a result the tumour cells initiate apoptosis and die
The researchers of this technology are : Axel H . Schtznthal , Nicos A . Petasis , Florence M
Hofman , Stan G . Louie and Thomas C . Chen
A patent application for this technology has been d (New technologies
Legal cases
AZT is the brand name of the drug developed by Borroughs welcome for treating AIDS
patients . It was developed with the help of a scientist at the National Institute of Health . It was a
monopoly product and Borroughs welcome obtained the patent for the same Borroughs had not
entirely developed the product on their own . A government scientist , at the National Institute of
Health , Dr .S .Broder , was involved with the development during the very crucial stage of testing
of the drug . Barr laboratories , under an agreement with the government was granted the license
to make this drug against payment of royalty to the government . When two companies , Barr
laboratories and Novopharm applied for license to the food and drugs Administration , to market
the generic version of AZT . The patent holder of AZT , Borroughs Wellcome , now Glaxo
Wellcome , sued these two firms , namely Bar laboratories and Novapharm for patent
infringement
The...
More Studies on compounds, search, patent, over, essays
Related searches on AIDS, HIV, AZT
- Plewe Michael reports
- sample studies on Plewe Michael
- essays on Search Patent
- Plewe Michael analysis
- merits of Tumor Cell Death
- disadvantages of HIV
- advantages and disadvantages of over
- AIDS summary
- cause and effect of 190
- 000 fallacies
- HIV test
- advantages of Plewe Michael
- Plewe Michael introduction





